One of the things I hark back to is that our particular sector actually is contributing in excess of 12% to the overall business expenditure on research and development in this country. So for us as a small technology group like us compared to some of our colleagues at the table, we are pretty active in terms of that investment dynamic for the country--as, I would suggest to you, writ large, are companies that have established products in the global marketplace.
Nobody is trying to suggest that one aspect of a SR and ED change will change the dynamic overall, but it's a slice in a series of opportunities for an integrated system of an investment climate that this country needs to look at. I look at countries like Indonesia, for instance, which is putting in $50 billion biotech strategies. I look at a nation like India, which has established a ministry of biotechnology. When we see South American companies making investments in the tens of billions of dollars in this technology, if they get it, why don't we?
Again, it's slices of opportunity and building for a bigger picture.